Concepedia

Karolina Stachlewska

KS

Statistics

Publications

4

Citations

378

H-Index

4

Active since

2021

Affiliations

Novo Nordisk (Denmark)(Current)

KU Leuven

Mossakowski Medical Research Institute, Polish Academy of Sciences

Velocity Clinical Research (United States)

Karolina Stachlewska is an author at Novo Nordisk (Denmark) specializing in glycemic control, medicine, and diabetes pharmacotherapy.

Publications per year

2021–2023

4

Publications

4

Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial

Chantal Mathieu, Björg Ásbjörnsdóttir, Harpreet S. Bajaj et al. · The Lancet · 2023 · 135 citations

, , +13

Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial

Athena Philis‐Tsimikas, Marisse Asong, Edward Franek et al. · The Lancet Diabetes & Endocrinology · 2023 · 131 citations

, , +15

A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100

Ildiko Lingvay, John B. Buse, Edward Franek et al. · Diabetes Care · 2021 · 96 citations · Full text

, , +17

<scp>DUAL</scp>I China: Improved glycemic control with<scp>IDegLira</scp>versus its individual components in a randomized trial with Chinese participants with type 2 diabetes uncontrolled on oral antidiabetic drugs

Weiqing Wang, Bue F. Ross Agner, Bin Luo et al. · Journal of Diabetes · 2022 · 16 citations · Full text

, , +17

1–4 of 4